Keywords
Identification
Biosurface activity
Antibacterial activity
Drug sensitivity test
Submitted : 2024-08-27
Accepted : 2024-09-11
Published : 2024-09-26
Abstract
In this study, six bacterial strains were isolated from the sediment, probiotic fermentation products, and lake sediments, they were identified as Bacillus amyloliquefaciens using genetic evolution analysis, which were named B3, B4, B5, XD3, YF6, and YF8. The comparison of the antibacterial activity, hemolytic activity, and antibiotic sensitivity of six Bacillus amyloliquefaciens strains laid a foundation for the development and application of antimicrobial peptide products. A surface activity assay was used to determine the production of biosurfactants in six Bacillus amyloliquefaciens strains. With Staphylococcus aureus and Escherichia coli as indicator bacteria, their antibacterial activity was determined using the agar diffusion method; the same diffusion method was used to determine the antibiotic susceptibility of Bacillus amyloliquefaciens. The results showed that the six Bacillus amyloliquefaciens strains had obvious biosurface activity, and the bacteria inhibited Staphylococcus aureus and Escherichia coli, from strong to weak: YF8, XD3, B3, B4, YF6, and B5. Strain YF8 had the best broad-spectrum bacteriostatic effect, followed by strain XD3. All Bacillus amyloliquefaciens strains were susceptible to 16 common drugs, except for Bacillus amyloliquefaciens strain YF8, which was intermediate to neomycin. The study shows that Bacillus amyloliquefaciens and secondary metabolites have the ability to produce a variety of active peptides, exert a certain inhibitory effect on common pathogens, and have the potential to develop as animal probiotics.
References
Lu JY, Zhou K, Huang WT, et al., 2019, A Comprehensive Genomic and Growth Proteomic Analysis of Antitumor Lipopeptide Bacillomycin Lb Biosynthesis in Bacillus amyloliquefaciens X030. Appl Microbiol Biotechnol, 103(18): 7647–7662.
Tran TD, Del CC, Hnasko R, et al., 2020, Bacillus amyloliquefaciens ALB65 Inhibits the Growth of Listeria monocytogenes on Cantaloupe Melons. Appl Environ Microbiol, 87(1): e01926.
Wang S, Wang Q, Zhai L, et al., 2020, Progress in the Antifungal Activity of B. amyloytica. The Chinese Journal of Microecology, 32(08): 971–978.
WoldemariamYohannes K, Wan Z, Yu Q, et al., 2020, Prebiotic, Probiotic, Antimicrobial, and Functional Food Applications of Bacillus amyloliquefaciens. J Agric Food Chem, 68(50): 14709–14727.
Xiang Y, Zhou H, Liu Y, et al., 2016, Isolation and Identification of Lipopeptide Antibiotics of Bacillus B1619 and Its Inhibitory Effect on Tomato Blight Bacteria. Chinese Agricultural Science, 49(15): 2935–2944.
Zhao Y, 2021, Progress in the Disease Resistance Mechanism of Bacillus amylinolitica. Research on Subtropical Agriculture, 17(3): 205–210.
Humphries R, Bobenchik AM, Hindler JA, et al., 2021, Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition. J Clin Microbiol, 59(12): e21321.
Chen X, Li X, Chen F, et al., 2023, Probiotic Properties and Antibacterial Activity of Five B. amylolitica Strains. Chinese Animal Husbandry and Veterinary Medicine, 50(5): 2082–2091.
Wang Z, Koirala B, Hernandez Y, et al., 2022, Bioinformatic Prospecting and Synthesis of a Bifunctional Lipopeptide Antibiotic that Evades Resistance. Science, 376(6596): 991–996.
He H, Su J, Teng K, et al., 2021, Bacillus amylefaciens. Modern Agricultural Science and Technology, 2021(02): 101–104.
Zhang B, Xu L, Ding J, et al., 2022, Natural Antimicrobial Lipopeptides Secreted by Bacillus spp. and Their Application in Food Preservation: A Critical Review. Trends in Food Science & Technology, (127): 26–37.
Penha RO, Vandenberghe L, Faulds C, et al., 2020, Bacillus Lipopeptides as Powerful Pest Control Agents for a More Sustainable and Healthy Agriculture: Recent Studies and Innovations. Planta, 251(3): 70.
Kalai-Grami L, Karkouch I, Naili O, et al., 2016, Production and Identification of Iturin A Lipopeptide from Bacillus methyltrophicus TEB1 for Control of Phoma tracheiphila. J Basic Microbiol, 56(8): 864–871.
Wang Y, Xu J, Shi J, et al., 2022, Draft Genome Sequence of a Lipopeptide-Producing Bacillus amyloliquefaciens Strain Isolated from Wheat Field Soil with Antagonistic Activity Against Azole-Resistant Fusarium graminearum. J Glob Antimicrob Resist, (29): 555–557.
Tran TD, Huynh S, Parker CT, et al., 2018, Complete Genome Sequences of Three Bacillus amyloliquefaciens Strains That Inhibit the Growth of Listeria monocytogenes In Vitro. Genome Announc, 6(25): e00579.
Jin P, Wang H, Tan Z, et al., 2020, Antifungal Mechanism of Bacillomycin D from Bacillus velezensis HN-2 Against Colletotrichum gloeosporioides Penz. Pestic Biochem Physiol, (163): 102–107.
Lv J, Da R, Cheng Y, et al., 2020, Mechanism of Antibacterial Activity of Bacillus amyloliquefaciens C-1 Lipopeptide toward Anaerobic Clostridium difficile. Biomed Res Int, (2020): 3104613.
Wang W, Li J, Chi H, 2021, Purification of Amylocyclicin W5 and Its Antibacterial Mechanism. Food Science, 42(07): 29–34.
Song X, Gao S, Li P, et al., 2024, Source and Mechanism of Action and Application of Antimicrobial Peptides. Advances in Animal Medicine, 45(04): 112–115.
Tan F, Pei M, Chai Y, et al., 2020, Progress in Antimicrobial Peptides and Fish Gut Health. Aquatic Science, 39(01): 135–142.
Martinez M, Goncalves S, Felicio MR, et al., 2019, Synergistic and Antibiofilm Activity of the Antimicrobial Peptide P5 Against Carbapenem-Resistant Pseudomonas aeruginosa. Biochim Biophys Acta Biomembr, 1861(7): 1329–1337.
Schofield BJ, Skarshewski A, Lachner N, et al., 2016, Near Complete Genome Sequence of the Animal Feed Probiotic, Bacillus amyloliquefaciens H57. Stand Genomic Sci, 11(1): 60.
Gan L, Zhao Y, Mahmood T, et al., 2020, Effects of Dietary Vitamins Supplementation Level on the Production Performance and Intestinal Microbiota of Aged Laying Hens. Poult Sci, 99(7): 3594–3605.
Kondrashov OV, Akimov SA, 2021, Regulation of Antimicrobial Peptide Activity via Tuning Deformation Fields by Membrane-Deforming Inclusions. Int J Mol Sci, 23(1): 326.
Wang Q, Zhang R, Wang Y, et al., 2022, Structural Modification of Antimicrobial Peptides and Artificial Intelligence Research and Development Strategy. Journal of Microbiology, 62(11): 4353–4366.
Colceriu MC, Aldea PL, Rachisan A, et al., 2023, Vesicoureteral Reflux and Innate Immune System: Physiology, Physiopathology, and Clinical Aspects. J Clin Med, 12(6): 2380.
Li X, Zuo S, Wang B, et al., 2022, Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides. Molecules, 27(9): 2675.
Qiu Y, Ma Y, Sha Y, et al., 2022, Progress in Molecular Genetic Manipulation of Bacillus amylolitica and Its Application. The Biotechnology Bulletin, 38(02): 205–217.
Farhat-Khemakhem A, Blibech M, Boukhris I, et al., 2018, Assessment of the Potential of the Multi-Enzyme Producer Bacillus amyloliquefaciens US573 as Alternative Feed Additive. J Sci Food Agric, 98(3): 1208–1215.
Luo X, Sun J, Lu Y, 2022, Progress on Biosynthesis, Antibacterial Mechanism and Application of Lipopeptide in Bacillus amylotica. Food Industry Science and Technology, 43(19): 462–470.